Factsheets: 📈 Markets 🎯 Mandates 📋 Case Studies 📘 SOPs 🏛 Trade Bodies 🏙 Cities 🌍 Countries 🇮🇳 Indian States ⚓ Ports 🏛️ SEZs 🤝 Blocs 📜 FTAs 🛤 Corridors ⚙ Verticals 📦 Commodities 🧮 Tools ⚖️ Compare 🌐 Bilateral Hubs 📚 Library 🎓 Academy ✍️ Essays 📰 Blog 🔤 Lexicon ❓ FAQ 📡 Authority Sources ⚡ Daily Pulse 📰 Topic Briefs 📡 Google Signals 🧭 Scope Scape cron-refreshed
Live factsheets · cron-refreshed

All factsheets at a glance

Command center →
📈 Markets
554
global + India · commodities + indices + shares + crypto + FX
minute
🎯 Mandates
69
sell + buy · live
daily
📋 Case Studies
37
closed · anonymised
weekly
📘 SOPs
42
step-by-step playbooks
weekly
🏛 Trade Bodies
1,350
291 baseline + 1059 hand-curated
monthly
🏙 Cities
1,584
global atlas
daily
🌍 Countries
184
multilateral
weekly
🇮🇳 Indian States
37
state trade profiles
monthly
⚓ Ports
52
global maritime gateways
monthly
🏛️ SEZs
31
global SEZ profiles
monthly
🤝 Blocs
28
tracked
monthly
📜 FTAs
526
active or signed
monthly
🛤 Corridors
37
tracked
monthly
⚙ Verticals
50
sectoral
weekly
📦 Commodities
51
HS-coded intelligence
monthly
🧮 Tools
105
free utilities
monthly
⚖️ Compare
pairwise combinations
monthly
🌐 Bilateral Hubs
184
India × every country
weekly
📚 Library
140
interconnected
monthly
🎓 Academy
25
trade education
monthly
✍️ Essays
30
long-form analysis
monthly
📰 Blog
34
editorial
weekly
🔤 Lexicon
312
glossary terms
monthly
❓ FAQ
155
curated Q&A
monthly
📡 Authority Sources
140
curated · vetted
hourly
⚡ Daily Pulse
145
rolling 5,000 cap
hourly
📰 Topic Briefs
29
permanent archive
hourly
📡 Google Signals
Trends·News·Alerts
hourly
🧭 Scope Scape
61
11 scopes
hourly

Medical Tourism · Commission-only · India ↔ EU

Medical Tourism — India to EU

India receives 2M+ medical tourists annually. EU patients travel to India for affordable, quality healthcare — cardiac surgery at 20% of EU cost, hip replacement at 15%, IVF at 10%. JCI-accredited hospitals in Chennai, Mumbai, Delhi are EU patient-ready.

JCI Accreditation NABH Cardiac Surgery Orthopaedics IVF Oncology Ayurveda Dental Tourism NITI Aayog Heal in India Apollo Fortis Manipal Medanta
USD 6B+ medical tourism revenue — EU patients among top-5 soMedical Tourism — India Export Value
EUR 2B+ — EU healthcare tourists spending in India (flight, EU Import Demand
8-12% of hospital/treatment revenue — medical tourism referrAJG Commission Range
+15% CAGR for India medical tourism — EU patient numbers groGrowth Rate
Bilateral trade · India ↔ EU

What moves on this corridor.

India exports → EU

USD 6B+ medical tourism revenue — EU patients among top-5 source markets for Indian hospitals

Top India states: Tamil Nadu (Chennai), Delhi NCR (Medanta, Fortis), Maharashtra (Mumbai), Karnataka (Bengaluru), Andhra Pradesh

EU exports → India

EUR 2B+ — EU healthcare tourists spending in India (flight, hospital, accommodation, post-care)

Top EU buyers: Germany, France, Netherlands, UK, Denmark, Sweden, Norway

Growth rate

+15% CAGR for India medical tourism — EU patient numbers growing as EU healthcare wait times increase

FTA duty impact

Services sector — no tariffs. Healthcare professional qualification recognition and patient data protection (GDPR) are key bilateral considerations.

Bilateral trade flow

India ↔ EU · the directions.

India to EU (Exports)

Cardiac surgery referrals (bypass, valve — 80% cost saving vs EU), orthopaedic referrals (hip/knee replacement — 85% cost saving), IVF and fertility referrals, oncology referrals, dental treatment packages, Ayurvedic wellness retreats

EU to India (Imports)

EU health insurance reimbursement (for cross-border care under EU Directive 2011/24), EU healthcare professional India training partnerships

Sector risk framework

Risks · assessment · mitigation.

Risk Assessment Mitigation
Market access and regulatory compliance Medium / Medium Engage EU-qualified compliance advisors and ensure all documentation meets destination market requirements.
Commission protection — relationship circumvention Medium / High NCNDA signed before any principal details disclosed. Written introduction letter on day of first contact.
3 Ps · viability analysis

Possibility · probability · plausibility.

Possibility

Is this trade structurally viable?

Yes — India has competitive manufacturing and service capability in this sector with growing EU demand.

Probability

Will this specific mandate close?

Medium-High for principals with appropriate certifications and documentation.

Plausibility

Does the commercial logic hold?

Fully coherent. Indian cost competitiveness combined with quality capabilities creates a strong EU value proposition.

Marketing mix · 10P analysis

The vertical through a 10P lens.

Product

Cardiac surgery referrals (bypass, valve — 80% cost saving vs EU), orthopaedic referrals (hip/knee r

Price

Indian products and services typically 30-50% below EU equivalent cost.

Place

India manufacturing/service hubs to EU distribution and retail channels.

Promotion

Sector-specific trade fairs, industry associations, digital channels.

People

Vinod Kumar Jain (India desk) and Amit Jain (EU desk) — commission-only principals.

Process

Three P filter → documentation verification → principal introduction → trial order → commercial agreement.

Physical Evidence

Certifications, test reports, samples, reference customer letters.

Partners

Sector-specific export promotion councils, industry associations, EU trade bodies.

Performance

8-12% of hospital/treatment revenue — medical tourism referral mandate with insurance coordination

Purpose

Building sustainable India-EU trade relationships that benefit both principals on a commission-only basis.

Practitioner intelligence

What works · what doesn't.

✓ Success conditions

What works

  • Ensuring all certifications and documentation are in order before approaching EU buyers.
  • Starting with smaller trial orders to build confidence before scaling to larger volumes.
  • Leveraging sector-specific trade fairs and industry networks for mandate origination.

✗ Failure modes

What doesn't work

  • Approaching EU buyers without proper product certifications — EU buyers will not engage.
  • Underpricing to win initial orders — unsustainable and damages long-term relationships.
Commission structure

How we get paid.

8-12% of hospital/treatment revenue — medical tourism referral mandate with insurance coordination

Deal type Rate Indicative value
Trial / First Order 4-6% of value Smaller initial order to build relationship and quality confidence
Annual Supply Contract 3-5% annual value Ongoing supply agreement — multi-year preferred
Sub-specialisations

Niches we operate in.

Niche

Medical Tourism Core Mandates

Direct India-EU supply and buy mandates in this sector

Niche

Triangular Routes

India-UAE-EU or India-Singapore-EU multilateral routing opportunities

Active mandates · Medical Tourism

What's open right now.

SELL Indian manufacturer seeking EU buyer — certified, documented, price-competitive. Contact AJG for introduction.
BUY EU buyer seeking India-origin supply in this sector. Commission-only introduction service.

Mandates anonymised. Introduced under NCNDA. Commission on completion. Submit your mandate →

Context & outlook

How this sector is moving.

Historical context

How this sector evolved

  • India has developed significant capability in this sector over the past three decades.
  • EU-India bilateral trade in this sector has grown consistently at above-average rates.
  • Increasing EU OEM and buyer interest in India as a reliable alternative to existing supply sources.

Future outlook 2025–2030

Where this is heading

  • India-EU FTA will create new commercial opportunities in this sector.
  • Growing EU interest in supply chain diversification benefits India's position.
  • Digitalisation and sustainability requirements creating new Indian capabilities.

India ↔ EU FTA impact

Medium-High impact

FTA will improve market access and reduce regulatory barriers for this sector.

Full FTA intelligence
Travelogue Forum

Have a question or insight on Medical Tourism? Start a thread in Markets & Logistics.

Discuss on the Forum →

Strategic Heat Map

Composite intelligence scores across seven dimensions · Updated April 2026 · Data sourced from bilateral trade statistics, EU Commission, MCI India, UNCTAD, and principal commercial experience.

Strategic Position
↑ Rising ↑ Accelerating
⏱ Typical first deal: 6 months
Trade Corridor Heat
India → EU 78/100
EU → India 30/100

Dimension Detail
Market Size 70
Growth Rate 80
Entry Ease 70
Regulatory Safety 58
Market Openness 60
Commission Yield 88
FTA Boost 65
Costing Intelligence
EU Import Duty (avg) 0% (services)
CBAM Exposure Exempt
Typical Commission 8–12% patient revenue
Incoterm (typical) N/A
Working Capital Cycle 0 days
Deal Count (target/yr) 5
Data Updated April 2026
Logistics Efficiency 98/100
Compliance Simplicity 62/100
Scores explained: All 0–100. Higher = more favourable. Entry Ease: 100 = no barriers. Regulatory Safety: 100 = low risk. Market Openness: 100 = low intermediary competition.

Multilateral Corridor Comparison — Global Overlay

Six global trade corridors plotted simultaneously on one radar. Outer polygon = stronger opportunity. Use this to compare which markets to prioritise for principal origination, route selection and mandate structuring.

Overlay Radar — 6 Corridors
EU
UAE
USA
UK
ASEAN
AUS
Score Matrix · 7 Dimensions × 6 Corridors (Higher = More Favourable)
DimensionEUUAEUSAUKASEANAUS
Mkt Size708275726058
Growth808582807875
Entry Ease708265727878
Reg Safety587255607072
Mkt Open605855606262
Commission889090887578
FTA Boost658038555868
🟢 ≥75 Strong · 🟡 50–74 Moderate · 🔴 <50 Challenging

Bilateral vs Multilateral Trade Intelligence

India–EU bilateral trade data alongside India's total global export position — and how India ranks as an EU supplier vs the world's top competing nations.

India ↔ EU · Bilateral
India → EU Exports USD 2,800M
EU → India Imports USD 350M
Trade Balance +USD 2,450M
Bilateral CAGR 18.5%
EU's share of India's total exports: 31.1%
India · Global Picture
Total India Exports USD 9,000M
Total India Imports USD 1,200M
India World Share 4.5%
Non-EU Opportunity 68.9% of exports
India in EU Market
EU Market Share 6.5% of EU imports
EU Supplier Rank #2 supplier
Trend ↑ Gaining share
FTA est.: Rank #1 within 3 yrs of India-EU FTA implementation.
EU Market Share — India vs Top Competitors (% of EU imports in this vertical)
India ⭐ 6.5%
Thailand 22.5%
Turkey 8.5%
Malaysia 5.5%
Source: UN Comtrade · Eurostat · WTO Statistics · 2023/2024. ⭐ = AJG focus corridor.

Competitive Intelligence — India vs Competing Nations in the EU Market

EU import market share by supplier nation. India's trajectory vs key competitors for this vertical. Source: UN Comtrade · Eurostat 2023/2024.

Supplier Nation EU Share Trend India Edge / Context Share Bar
Thailand 22.5% Bumrungrad hospital
Turkey 8.5% JCI accredited
Malaysia 5.5% Penang hub
India ⭐ 6.5%
UAE 4% Cleveland Clinic Dubai
India currently ranks #2 among EU suppliers for this vertical — trend: gaining. India-EU FTA expected to improve rank by 2–3 positions within 3 years.

India-EU FTA Duty Saving Estimator

Indicative duty savings when India-EU FTA enters into force (target 2026+). Current EU MFN duty: 0% (services). FTA target: 0% (phased).

On USD 1M FOB
Nil
annual duty saving
On USD 5M FOB
Nil
annual duty saving
On USD 10M FOB
Nil
annual duty saving
FTA saving = EU MFN duty × shipment value. Applies when India-EU FTA is in force. Phased tariff schedules may reduce Year 1 saving vs full rate. Use the FTA Savings Estimator tool for HS-code specific calculations.

Franchise opportunity · Medical Tourism

Operate Medical Tourism mandates in your territory.

EUR 15,000–50,000 initial fee · 60/40 commission split · Document library white-labelled · Exclusive territory.

Franchise enquiry Sector documents

Every Direction. Every Configuration. Commission-Only.

Not just bilateral India↔EU. AJG brokers all directions — Unilateral, Bilateral, Trilateral, Multilateral. Each route below is an active mandate configuration we work across both principals.

TRILATERAL
India → UAE → EU
Via: Dubai JAFZA
UAE CEPA gives 0% duty for Indian goods into UAE. UAE-EU trade then routes finished goods to Europe. Significant duty + logistics advantage.
💡 8–15% duty saving on select HS codes vs direct India→EU
Key Cities
India Uae Cepa → India Eu Fta →
TRILATERAL
India → UAE → Africa
Via: Dubai / Jebel Ali
UAE is the distribution hub for 54 African countries. Indian goods transit Dubai for onward shipping to East, West and Southern Africa.
💡 Reduced transit time + duty optimisation across 54 African markets
Key Cities
India Uae Cepa →
TRILATERAL
India → Singapore → ASEAN
Via: Singapore (CECA)
India-Singapore CECA enables preferential access. Singapore as ASEAN hub routes Indian goods and services across 10 ASEAN nations.
💡 ASEAN single market access (660M consumers) via Singapore hub
Key Cities
India Singapore Ceca → India Asean Aifta →
TRILATERAL
EU → India → GCC
Via: India (manufacturing & distribution)
European companies use India as a manufacturing/service hub to access the 6-country Gulf market. India value-add lowers cost vs direct EU→GCC.
💡 India manufacturing cost advantage + preferential GCC access
Key Cities
India Eu Fta → India Uae Cepa →
Submit Multilateral Mandate → View All Active Mandates 36 Trade Corridors

📊 Vertical monthly · refreshed monthly

Trade Usd B
9.0 USD B
Growth Pct
16.0%
Top Product
Cardiac & Orthopaedic
Top Market Eu
UK
Active Mandates
3.0
Monthly Enquiries
7.0

Data refresh: monthly · from data/data-monthly.php · last reviewed by AJG editorial.

v129.1 · vertical-deep-data · medical-tourism

Live Medical Tourism intelligence

📘 Standard operating procedures · 1

Medical Tourism — EU Patients to India · 6 steps

India' healthcare system provides world-class treatment in cardiac surgery, orthopaedics, oncology, fertility treatment, and Ayurvedic wellness at 20-40% of EU private hospital costs. JCI (Joint Commission International) accreditation and NABH (National Accreditation Board for Hospitals) are the primary quality credentials for EU patient attractio…

  1. Market and Regulatory Assessment — 4-8 weeks
  2. EU Compliance and Certification Programme — 3-12 months depending on sector
  3. EU Buyer Identification and Qualification — 3-6 months
  4. Commercial Negotiation and Contract — 4-8 weeks
  5. Order Execution, Quality Control, and Pre-Shipment — Throughout production cycle
  6. Shipment, Documentation, FTA Optimisation, and Post-Export Incentives — 2-4 days per shipment
PhiloJain Music
Loading…

Explore

Explore the AJG knowledge graph

Every page in the AJG platform cross-links to these primary entities. Click any pill to explore that branch of the knowledge graph.

All hubs · 80 surfaces · click to expand ↓